BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6765952)

  • 1. Changes in thyroid functions in patients with euthyroid Graves' disease.
    Tamai H; Nakagawa T; Ohsako N; Fukino O; Takahashi H; Matsuzuka F; Kuma K; Nagataki S
    J Clin Endocrinol Metab; 1980 Jan; 50(1):108-12. PubMed ID: 6765952
    [No Abstract]   [Full Text] [Related]  

  • 2. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
    Chopra IJ; Chopra U; Orgiazzi J
    J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in thyroid function in euthyroid subjects with a family history of Graves' disease: a follow-up study of 69 patients.
    Tamai H; Ohsako N; Takeno K; Fukino O; Takahashi H; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1123-7. PubMed ID: 6774999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.
    Rajatanavin R; Mahatumarat P; Poochanugool L; Kumpolpunth S; Himathongkam T
    J Med Assoc Thai; 1981 Jan; 64(1):11-8. PubMed ID: 6163837
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid function and histology in forty-five patients with hyperthyroid Graves' disease in clinical remission more than ten years after thionamide drug treatment.
    Hirota Y; Tamai H; Hayashi Y; Matsubayashi S; Matsuzuka F; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):165-9. PubMed ID: 2415549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of the response to TRH in the exophthalmic syndrome.
    Simescu M; Negoescu I; Constantinescu A
    Endocrinologie; 1977; 15(2):143-6. PubMed ID: 68541
    [No Abstract]   [Full Text] [Related]  

  • 10. [TRH and thyroid suppression test in normal subjects (8) and thyroid disease (49) (author's transl)(proceedings)].
    Codaccioni JL; Wassermann-Suret AM; Carayon P; Jaquet P
    Ann Endocrinol (Paris); 1976; 37(4):321-2. PubMed ID: 828843
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto's thyroiditis: lack of correlation with inheritance of HLA-B8.
    Chopra IJ; Solomon DH; Chopra U; Yoshihara E; Terasaki PI; Smith F
    J Clin Endocrinol Metab; 1977 Jul; 45(1):45-54. PubMed ID: 406273
    [No Abstract]   [Full Text] [Related]  

  • 12. Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.
    Clifton-Bligh P; Silverstein GE; Burke G
    J Clin Endocrinol Metab; 1974 Apr; 38(4):531-8. PubMed ID: 4206830
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone (a test to diagnose Graves' ophthalmopathy).
    Hyman BN; Johnson PC
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(3 Pt 2):OP524-8. PubMed ID: 50663
    [No Abstract]   [Full Text] [Related]  

  • 15. [Responses to the TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease (author's transl)].
    Tamai H; Suematsu H; Takahashi H; Esaki M; Kurokawa N; Aoki H; Kuma K; Matsuzuka F; Nagataki S; Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1978 Jan; 54(1):68-77. PubMed ID: 415909
    [No Abstract]   [Full Text] [Related]  

  • 16. [TRH stimulation test. II. Evaluation of thyroid response].
    Dussault JH; Coulombe P
    Union Med Can; 1973 Dec; 102(12):2485-9. PubMed ID: 4204002
    [No Abstract]   [Full Text] [Related]  

  • 17. Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease.
    Tamai H; Nagai K; Uehata S; Komaki G; Kiyohara K; Miyauchi A; Kuma K; Kumagai LF; Nagataki S
    Exp Clin Endocrinol; 1990 Dec; 96(3):279-87. PubMed ID: 2128053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assessment of thyroid function and structure.
    Bain J; Walfish PG
    Otolaryngol Clin North Am; 1978 Jun; 11(2):419-43. PubMed ID: 99712
    [No Abstract]   [Full Text] [Related]  

  • 19. Spectrum of pituitary alterations with mild and severe thyroid impairment.
    Bigos ST; Ridgway EC; Kourides IA; Maloof F
    J Clin Endocrinol Metab; 1978 Feb; 46(2):317-25. PubMed ID: 108289
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thyroidal response to thyrotropin-releasing hormone (TRH) as a predictive test of remission in euthyroid patients with Graves' disease].
    Takahashi H
    Fukuoka Igaku Zasshi; 1984 May; 75(5):241-51. PubMed ID: 6436156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.